Nutriband files Reg FD press release Form 8-K

Q: Which Nutriband (NTRB) securities are listed and where are they traded?

Nutriband’s common stock trades under the symbol NTRB, and its warrants trade under NTRBW. Both classes of securities are listed on The Nasdaq Stock Market LLC, as noted in the Form 8-K filing.

Q: Who signed Nutriband Inc.’s (NTRB) Form 8-K and in what capacity?

The Form 8-K was signed on behalf of Nutriband Inc. by Gareth Sheridan. He signed the report in his capacity as Chief Executive Officer, confirming the company’s authorization of the filing.

Nutriband Inc. filed a current report on Form 8-K to furnish information under Item 7.01, Regulation FD Disclosure.

Accepted by SEC EDGAR 10/28/2025 - 12:00 PM EDT

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Nutriband Inc. filed a current report on Form 8-K to furnish information under Item 7.01, Regulation FD Disclosure. The company refers readers to an attached press release dated October 28, 2025, filed as Exhibit 99.1.

Nutriband’s common stock (symbol NTRB) and warrants (symbol NTRBW) are listed on The Nasdaq Stock Market LLC. The report is signed on behalf of Nutriband Inc. by Chief Executive Officer Gareth Sheridan.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Terms

Regulation FD Disclosure, emerging growth company, Inline XBRL

3 terms

Regulation FD Disclosure regulatory

"Item 7.01. Regulation FD Disclosure."

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Inline XBRL technical

"Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nutriband Inc. (NTRB) file in this Form 8-K?

Nutriband Inc. filed a Form 8-K current report to furnish information under Item 7.01, Regulation FD Disclosure. The filing primarily points to an attached press release dated October 28, 2025, identified as Exhibit 99.1.

Which Nutriband (NTRB) securities are listed and where are they traded?

Nutriband’s common stock trades under the symbol NTRB, and its warrants trade under NTRBW. Both classes of securities are listed on The Nasdaq Stock Market LLC, as noted in the Form 8-K filing.

What is the purpose of the Regulation FD Disclosure item in Nutriband’s 8-K?

The Regulation FD Disclosure item in Nutriband’s Form 8-K indicates the company is furnishing information to the market on a fair-disclosure basis. In this case, it directs investors to a press release dated October 28, 2025, filed as Exhibit 99.1.

What exhibits are included with Nutriband Inc.’s (NTRB) Form 8-K?

The Form 8-K includes Exhibit 99.1, described as a press release issued October 28, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document, as required for electronic reporting.

Who signed Nutriband Inc.’s (NTRB) Form 8-K and in what capacity?

The Form 8-K was signed on behalf of Nutriband Inc. by Gareth Sheridan. He signed the report in his capacity as Chief Executive Officer, confirming the company’s authorization of the filing.

What is the date of the Nutriband (NTRB) press release referenced in the 8-K?

The Form 8-K specifies that the referenced press release was issued on October 28, 2025. This press release is filed as Exhibit 99.1 and serves as the substantive content for the Regulation FD Disclosure item.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported); October 28, 2025

Nutriband Inc.

Nevada		000-40854		81-1118176
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

121 S. Orange Ave. Suite 1500

Orlando, Florida

32801

(Address of Principal Executive Offices)

(Zip Code)

(407) 377-6695

Registrant’s Telephone Number, Including Area Code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	NTRB	The Nasdaq Stock Market LLC
Warrants	NTRBW	The Nasdaq Stock Market LLC

Item 7.01. Regulation FD Disclosure.

See attached press release dated October 28, 2025.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following exhibits are being filed with this Current Report on Form 8-K:

99.1		Press Release issued October 28, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

	NUTRIBAND, INC.

Date: October 28, 2025	By:	/s/ Gareth Sheridan
		R: Gareth Sheridan
		Chief Executive Officer

Source: View Original Filing on SEC EDGAR